CM
ABMD

Caption Management’s Abiomed Inc ABMD Stock Holding History

Caption Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$651K – 2065
2021
Q3 		$651K Buy
+2,000
New +$678K 0.01% 1152
2021
Q1 		– Sell
-13,000
Closed -$4.22M – 1486
2020
Q4 		$4.22M Buy
13,000
+2,000
+18% +$553K 0.1% 264
2020
Q3 		$3.05M Buy
+11,000
New +$3.17M 0.07% 316
2020
Q1 		– Sell
-2,700
Closed -$461K – 1158
2019
Q4 		$461K Sell
2,700
-2,600
-49% -$482K 0.02% 641
2019
Q3 		$942K Buy
+5,300
New +$1.15M 0.05% 391

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Caption Management's ABMD Position: Q4 2021 in Review

Caption Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 2,000 shares — an estimated $651K sold.

Caption Management first reported a position in ABMD in Q3 2019 and held it in 5 quarters. The position peaked at $4.22M in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Caption Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Caption Management sold 2,000 Abiomed Inc shares in Q4 2021, an estimated $651K.
  • Caption Management first reported a position in Abiomed Inc in Q3 2019 and held it in 5 quarters.
  • Caption Management's Abiomed Inc position peaked at $4.22M in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.